| Systematic immunotherapy target discovery using genome-scale in vivo CRISPR screens in CD8 T cells MB Dong, G Wang, RD Chow, L Ye, L Zhu, X Dai, JJ Park, HR Kim, ... Cell 178 (5), 1189-1204. e23, 2019 | 283 | 2019 |
| In vivo CRISPR screening in CD8 T cells with AAV–Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastoma L Ye, JJ Park, MB Dong, Q Yang, RD Chow, L Peng, Y Du, J Guo, X Dai, ... Nature biotechnology 37 (11), 1302-1313, 2019 | 172 | 2019 |
| One-step generation of modular CAR-T cells with AAV–Cpf1 X Dai, JJ Park, Y Du, HR Kim, G Wang, Y Errami, S Chen Nature Methods 16 (3), 247-254, 2019 | 160 | 2019 |
| A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy L Ye, JJ Park, L Peng, Q Yang, RD Chow, MB Dong, SZ Lam, J Guo, ... Cell metabolism 34 (4), 595-614. e14, 2022 | 125 | 2022 |
| CRISPR-GEMM pooled mutagenic screening identifies KMT2D as a major modulator of immune checkpoint blockade G Wang, RD Chow, L Zhu, Z Bai, L Ye, F Zhang, PA Renauer, MB Dong, ... Cancer discovery 10 (12), 1912-1933, 2020 | 105 | 2020 |
| Up-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer Y Liu, Y Du, X Hu, L Zhao, W Xia BMC cancer 18, 1-11, 2018 | 81 | 2018 |
| Long non-coding RNA BLACAT1 promotes breast cancer cell proliferation and metastasis by miR-150-5p/CCR2 X Hu, Y Liu, Y Du, T Cheng, W Xia Cell & bioscience 9, 1-9, 2019 | 49 | 2019 |
| Downregulation of BANCR promotes aggressiveness in papillary thyroid cancer via the MAPK and PI3K pathways J Zhang, Y Du, X Zhang, M Li, X Li Journal of Cancer 9 (7), 1318, 2018 | 41 | 2018 |
| SIX1 activates STAT3 signaling to promote the proliferation of thyroid carcinoma via EYA1 D Kong, A Li, Y Liu, Q Cui, K Wang, D Zhang, J Tang, Y Du, Z Liu, G Wu, ... Frontiers in oncology 9, 1450, 2019 | 36 | 2019 |
| Massively parallel knock-in engineering of human T cells X Dai, JJ Park, Y Du, Z Na, SZ Lam, RD Chow, PA Renauer, J Gu, S Xin, ... Nature biotechnology 41 (9), 1239-1255, 2023 | 34 | 2023 |
| CAR-T cells targeting TSHR demonstrate safety and potent preclinical activity against differentiated thyroid cancer H Li, X Zhou, G Wang, D Hua, S Li, T Xu, M Dong, X Cui, X Yang, Y Wu, ... The Journal of Clinical Endocrinology & Metabolism 107 (4), 1110-1126, 2022 | 28 | 2022 |
| LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15 Y Liu, T Cheng, Y Du, X Hu, W Xia BMC molecular and cell biology 21, 1-11, 2020 | 25 | 2020 |
| The association between Foxp3 polymorphisms and risk of graves' disease: A systematic review and meta-analysis of observational studies H Li, X Li, Y Du, Z Yang, Z Lv Frontiers in endocrinology 11, 392, 2020 | 25 | 2020 |
| Comprehensive analysis of long noncoding RNA–mRNA co-expression patterns in thyroid cancer Y Du, W Xia, J Zhang, D Wan, Z Yang, X Li Molecular Biosystems 13 (10), 2107-2115, 2017 | 25 | 2017 |
| Current landscape of personalized clinical treatments for triple-negative breast cancer J Zhang, Y Xia, X Zhou, H Yu, Y Tan, Y Du, Q Zhang, Y Wu Frontiers in Pharmacology 13, 977660, 2022 | 19 | 2022 |
| Cyclin-Dependent Kinase Inhibitors Function as Potential Immune Regulators via Inducing Pyroptosis in Triple Negative Breast Cancer T Xu, Z Wang, J Liu, G Wang, D Zhou, Y Du, X Li, Y Xia, Q Gao Frontiers in Oncology 12, 820696, 2022 | 17 | 2022 |
| RETRACTED ARTICLE: MicroRNA-423 Drug Resistance and Proliferation of Breast Cancer Cells by Targeting ZFP36 W Xia, Y Liu, Y Du, T Cheng, X Hu, X Li OncoTargets and therapy, 769-782, 2020 | 17 | 2020 |
| ZW10 interacting kinetochore protein may serve as a prognostic biomarker for human breast cancer: An integrated bioinformatics analysis HN Li, WH Zheng, YY Du, G Wang, ML Dong, ZF Yang, XR Li Oncology Letters 19 (3), 2163-2174, 2020 | 16 | 2020 |
| MiR-205-5p/GGCT attenuates growth and metastasis of papillary thyroid cancer by regulating CD44 HN Li, HM Zhang, XR Li, J Wang, T Xu, SY Li, ML Dong, G Wang, XQ Cui, ... Endocrinology 163 (4), bqac022, 2022 | 14 | 2022 |
| CRISPR-GEMM Pooled Mutagenic Screening Identifies KMT2D as a Major Modulator of Immune Checkpoint Blockade. Cancer Discov 2020; 10 (12): 1912–33. doi: 10.1158/2159-8290 G Wang, RD Chow, L Zhu, Z Bai, L Ye, F Zhang, PA Renauer, MB Dong, ... CD-19-1448.[Europe PMC free article][Abstract][CrossRef][Academic Search], 0 | 10 | |
